DK3302527T3 - Manipuleret CCL20-låst-dimerpolypeptid - Google Patents
Manipuleret CCL20-låst-dimerpolypeptid Download PDFInfo
- Publication number
- DK3302527T3 DK3302527T3 DK16804201.8T DK16804201T DK3302527T3 DK 3302527 T3 DK3302527 T3 DK 3302527T3 DK 16804201 T DK16804201 T DK 16804201T DK 3302527 T3 DK3302527 T3 DK 3302527T3
- Authority
- DK
- Denmark
- Prior art keywords
- ccl20
- manipulated
- dimer polypeptide
- locked dimer
- locked
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562170347P | 2015-06-03 | 2015-06-03 | |
PCT/US2016/034956 WO2016196429A1 (en) | 2015-06-03 | 2016-05-31 | An engineered ccl20 locked dimer polypeptide |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3302527T3 true DK3302527T3 (da) | 2020-03-30 |
Family
ID=57441846
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK16804201.8T DK3302527T3 (da) | 2015-06-03 | 2016-05-31 | Manipuleret CCL20-låst-dimerpolypeptid |
Country Status (8)
Country | Link |
---|---|
US (1) | US10738095B2 (da) |
EP (2) | EP3666282A1 (da) |
JP (1) | JP6786526B2 (da) |
AU (1) | AU2016271292B2 (da) |
CA (1) | CA2988086C (da) |
DK (1) | DK3302527T3 (da) |
ES (1) | ES2776243T3 (da) |
WO (1) | WO2016196429A1 (da) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180325931A1 (en) | 2017-01-21 | 2018-11-15 | Ningbo Zhiming Biotechnology Co., Ltd. | Use of paeoniflorin-6'-o-benzenesulfonate in treatment of sjögren's syndrome |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
US4160452A (en) | 1977-04-07 | 1979-07-10 | Alza Corporation | Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina |
US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
US5288931A (en) * | 1991-12-06 | 1994-02-22 | Genentech, Inc. | Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation |
US6479258B1 (en) | 1995-12-07 | 2002-11-12 | Diversa Corporation | Non-stochastic generation of genetic vaccines |
US7390619B1 (en) | 1998-02-11 | 2008-06-24 | Maxygen, Inc. | Optimization of immunomodulatory properties of genetic vaccines |
US20030215421A1 (en) | 1999-07-21 | 2003-11-20 | Mcdonald John R. | Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders |
US6645491B1 (en) | 1999-02-03 | 2003-11-11 | Schering Corporation | Method for treating inflammatory conditions using an antibody to MIP-3α |
US20020004041A1 (en) | 1999-02-19 | 2002-01-10 | Albert Matthew L. | Methods for abrogating a cellular immune response |
US6723538B2 (en) | 1999-03-11 | 2004-04-20 | Micromet Ag | Bispecific antibody and chemokine receptor constructs |
GB9912350D0 (en) * | 1999-05-26 | 1999-07-28 | European Molecular Biology Lab Embl | Modified cytokine |
WO2001017558A2 (en) | 1999-09-08 | 2001-03-15 | Schering Corporation | Novel uses of mammalian ccr6 receptors and related reagents |
US20020061599A1 (en) | 1999-12-30 | 2002-05-23 | Elling Christian E. | Method of identifying ligands of biological target molecules |
US6843987B2 (en) | 2000-02-02 | 2005-01-18 | Schering Corporation | Mammalian cytokines; receptors; related reagents and methods |
AU4761601A (en) | 2000-04-11 | 2001-10-23 | Genentech Inc | Multivalent antibodies and uses therefor |
US20040197329A1 (en) | 2000-10-13 | 2004-10-07 | Yasunori Nakayama | Remedies or preventives for rheumatoid arthritis |
WO2002062850A2 (en) | 2001-02-02 | 2002-08-15 | Millennium Pharmaceuticals, Inc. | Hybrid antibodies and uses thereof |
US7468253B2 (en) | 2001-06-07 | 2008-12-23 | Chemocentryx, Inc. | Method for multiple chemokine receptor screening for antagonists using RAM assay |
FI117667B (fi) * | 2001-07-05 | 2007-01-15 | Univ Zuerich | Farmaseuttinen koostumus, joka soveltuu käytettäväksi ortopediassa ja hammaslääketieteessä |
MXPA04002575A (es) | 2001-09-20 | 2004-06-18 | Schering Corp | Quimiocinas como adyuventes de respuesta inmune. |
US20030140361A1 (en) | 2001-09-24 | 2003-07-24 | Brennan Thomas J. | CCR6 chemokine receptor disruptions, compositions and methods relating thereto |
US7442512B2 (en) | 2001-11-30 | 2008-10-28 | Chemocentryx, Inc. | Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
US7413866B2 (en) | 2001-11-30 | 2008-08-19 | Chemocentryx, Inc. | Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
US7507787B2 (en) | 2001-12-03 | 2009-03-24 | The University Of British Columbia | Effectors of innate immunity |
US20060275295A1 (en) | 2001-12-18 | 2006-12-07 | Denis Jullien | Activity of THAP-family chemokine-binding domains |
US20060240016A1 (en) | 2001-12-18 | 2006-10-26 | Luc Aguilar | Activity of THAP-family chemokine-binding domains |
US7858297B2 (en) | 2001-12-18 | 2010-12-28 | Centre National De La Recherche Scientifique Cnrs | Chemokine-binding protein and methods of use |
WO2004024075A2 (en) | 2002-09-11 | 2004-03-25 | Medical College Of Georgia Research Institute, Inc. | Chemokine receptor antagonists as therapeutic agents |
US20050148029A1 (en) | 2003-09-29 | 2005-07-07 | Biosite, Inc. | Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes |
CA2572334A1 (en) | 2004-07-01 | 2006-01-19 | New York University | Compositions and methods for modulation of ror.gamma.t |
US7399831B2 (en) | 2004-10-25 | 2008-07-15 | The Brigham And Women's Hospital, Inc. | Targeted delivery of biological factors using self-assembling peptide nanofibers |
EP1814911A2 (en) | 2004-11-04 | 2007-08-08 | New England Medical Center Hospitals, Inc. | G protein coupled receptor agonists and antagonists and methods of use |
US7612181B2 (en) | 2005-08-19 | 2009-11-03 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
US9726673B2 (en) | 2005-11-23 | 2017-08-08 | Genentech, Inc. | Methods and compositions related to B cell assays |
ATE437889T1 (de) | 2005-12-02 | 2009-08-15 | Apceth Gmbh & Co Kg | Chemokin-mucin fusionsproteine mit einer gpi- ankerdomäne und deren verwendung als tumor-immun- adjuvanzien oder in der geweberegeneration |
CN105837690A (zh) | 2006-06-12 | 2016-08-10 | 新兴产品开发西雅图有限公司 | 具有效应功能的单链多价结合蛋白 |
BRPI0720647A2 (pt) | 2006-12-29 | 2014-01-14 | Osprey Pharmaceuticals Usa Inc | Processos de seleção e produção de toxinas modificadas, conjugados contendo toxinas modificadas e usos dos mesmos |
US7923016B2 (en) * | 2008-02-27 | 2011-04-12 | Medical College Of Wisconsin | Engineered CXCL12 α locked dimer polypeptide |
WO2010037402A1 (en) | 2008-10-02 | 2010-04-08 | Dako Denmark A/S | Molecular vaccines for infectious disease |
SG10201610247QA (en) | 2008-12-03 | 2017-02-27 | Genmab As | Antibody variants having modifications in the constant region |
EP2393492A1 (en) | 2009-02-09 | 2011-12-14 | Boehringer Ingelheim International GmbH | New pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
US20120269765A1 (en) | 2009-07-24 | 2012-10-25 | Garcia K Christopher | Cytokine compositions and methods of use thereof |
WO2011056650A2 (en) | 2009-10-27 | 2011-05-12 | Michael Zasloff | Methods and compositions for treating and preventing viral infections |
NZ611269A (en) | 2010-11-19 | 2015-03-27 | Eisai R&D Man Co Ltd | Neutralizing anti-ccl20 antibodies |
UY33827A (es) | 2010-12-22 | 2012-07-31 | Abbott Lab | Proteínas de unión a media-inmunoglobulina y sus usos |
AU2012212047A1 (en) * | 2011-02-03 | 2013-08-22 | Xoma Technology Ltd. | Methods and materials for enhancing functional protein expression in bacteria |
TWI671315B (zh) | 2011-03-28 | 2019-09-11 | 法商賽諾菲公司 | 具有交叉結合區定向之雙重可變區類抗體結合蛋白 |
WO2012142501A1 (en) | 2011-04-13 | 2012-10-18 | Revalesio Corporation | Compositions and methods for inhibiting and/or modulating effector t-cells involved in inflammatory neurodegenerative disease |
AU2013358892B2 (en) | 2012-12-13 | 2018-06-21 | Aduro Biotech, Inc. | Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use |
-
2016
- 2016-05-31 EP EP19212936.9A patent/EP3666282A1/en active Pending
- 2016-05-31 WO PCT/US2016/034956 patent/WO2016196429A1/en active Application Filing
- 2016-05-31 AU AU2016271292A patent/AU2016271292B2/en active Active
- 2016-05-31 US US15/579,114 patent/US10738095B2/en active Active
- 2016-05-31 EP EP16804201.8A patent/EP3302527B1/en active Active
- 2016-05-31 ES ES16804201T patent/ES2776243T3/es active Active
- 2016-05-31 DK DK16804201.8T patent/DK3302527T3/da active
- 2016-05-31 JP JP2017562777A patent/JP6786526B2/ja active Active
- 2016-05-31 CA CA2988086A patent/CA2988086C/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2018517707A (ja) | 2018-07-05 |
US20180237486A1 (en) | 2018-08-23 |
AU2016271292A1 (en) | 2017-12-21 |
WO2016196429A1 (en) | 2016-12-08 |
JP6786526B2 (ja) | 2020-11-18 |
EP3302527A4 (en) | 2018-12-12 |
EP3302527B1 (en) | 2020-01-08 |
EP3302527A1 (en) | 2018-04-11 |
CA2988086C (en) | 2023-09-19 |
US10738095B2 (en) | 2020-08-11 |
EP3666282A1 (en) | 2020-06-17 |
AU2016271292B2 (en) | 2022-04-14 |
CA2988086A1 (en) | 2016-12-08 |
ES2776243T3 (es) | 2020-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3197453T3 (da) | Kimært protein | |
DK3283625T3 (da) | Nukleasemedieret genomeditering | |
DK3331869T3 (da) | Muscarinagonister | |
DK4089113T3 (da) | Polypeptider | |
DK3305788T3 (da) | Janus-kinase-hæmmer | |
DK3723783T3 (da) | Mitokondrie-målrettede peptider | |
DK3331528T3 (da) | Muskarinagonister | |
DK3360890T3 (da) | Genterapi | |
DK3753929T3 (da) | Dimere kontrastmidler | |
DK3331529T3 (da) | Muskarinagonister | |
DK3310450T3 (da) | Olie-vand-separator | |
DK3270930T3 (da) | Præeklampsi | |
DK3702450T3 (da) | Protein | |
DK3259358T3 (da) | Forøget proteinekspression | |
DK3394281T3 (da) | Gærcelle | |
DK3292136T3 (da) | Penicillin-g-acylaser | |
DE112015006486A5 (de) | Inkubationsrinne | |
DK3274482T3 (da) | Stenborsknop | |
DK3099793T3 (da) | Protein | |
DK3318308T3 (da) | Badmintonketsjer | |
DE112015005906A5 (de) | Gurtschlossbringer | |
DE112016005599A5 (de) | Strahlungsgrill | |
KR20180085014A (ko) | 펩티드 조성물 | |
ES1140083Y (es) | Descompatactador tetrafunción | |
DE102015206660A8 (de) | Plattenaufteilanlage |